In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

Ozempic side effects are a hot topic but don’t panic – our experts are here to help. Here’s what to expect and how to ...

In today’s Health Alert, two popular weight loss drugs went head-to-head in a clinical trial – and one came out on top.

Zepbound won on all measures of effectiveness in a trial presented Monday at an obesity conference, spurring an average of 47 ...

A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that participants ...

(Reuters) -Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk (NYSE: NVO )’s Wegovy across five ...

Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...

NEW YORK (Reuters) -Health and wellness companies are embracing weight-loss drugs and building offerings around them in an ...

INDIANAPOLIS — Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival ...

INDIANAPOLIS — Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival ...